Merck KGaA Interview: China E-Health Push A ‘Long-Term Strategy’
Merck KGaA's alliances with Chinese internet giant Tencent and Alibaba Health is part of the German group's long-term strategy for China and reflects the high speed with which digital healthcare is evolving there, global operations head Chris Round tells Scrip.
You may also be interested in...
The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.
The EMA has recommended Sanofi’s anti-CD38 antibody Sarclisa as a combination-based third-line treatment for multiple myeloma, after US approval earlier in March.